700 patients110,866 observations180 daysLIVE
← Patients

Patient P-02081

Synthetic patientMETA-24 · Day 156 · 55–64 · M · baseline S20Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Deteriorating
GI state
Favorable
Inflammatory state
Deteriorating
Nutritional resilience
Favorable
Discontinuation risk
12%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 META-24 started — Baseline state S20
  2. Day 96 DT-01 recommended — Dosing / Timing Recommendation DT-01
  3. Day 97 Patient accepted — Started DT-01 in the companion
  4. Day 102 No meaningful change — Dosing / Timing Recommendation DT-01

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Toxicity+17
  • Inflammatory activity+8
  • Treatment adherence+4
  • Nutritional resilience-2

What helped?

  • Dosing / Timing Recommendation DT-01Day 96
    Result: no meaningful change
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes
Wearable
85 min
stable · -1.9 vs previous 14 d
Sleep duration
Wearable
7.9 h
stable · +0.1 vs previous 14 d
Energy level
Daily log
6.6/10
stable · -0.1 vs previous 14 d
Steps
Wearable
8,536
stable · -256 vs previous 14 d
GI burden
Companion
16.3/100
worsening · +2.6 vs previous 14 d
Adherence
Companion
95.8 %
stable · -1.6 vs previous 14 d
Sleep quality
Wearable
53.1/100
stable · -0.2 vs previous 14 d
Glucose, CGM daily mean
CGM
115 mg/dL
stable · -4.1 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →

Heading towards failing · 93 from the failing basin, 10 from restoration.

Would help
  • No untried action with strong evidence. Compose one from primitives.
  • More protein
    GI -5.5 next day on high-intake days · n 20
Would not help
  • DT-01 Dosing / Timing Recommendation
    already tried, no meaningful change
  • Keep ultra-processed low
    GI +5.8 next day on high-intake days · n 20
  • Keep alcohol low
    GI +4.6 next day on high-intake days · n 19
  • Keep simple carbs low
    GI +2.4 next day on high-intake days · n 12
State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

  • Ultra-processed food
    +5.8detractor · 95%
  • Protein
    -5.5supporter · 95%
  • Alcohol
    +4.6detractor · 95%
  • Simple carbohydrates
    +2.4detractor · 60%
  • Dietary fat load
    +1.7no signal · 39%
  • Caffeine
    +1.7no signal · 25%
  • Insoluble fibre
    -0.2no signal · 15%
  • Histamine load
    +0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Inflammatory signalling ↑60
    • DNAIL6 -174 variant raises baseline inflammatory tone
    • MicrobiomeBacteroides fragilis expansion
    • WearableHRV 37 ms, trending down
  • Butyrate / short-chain fatty acid production ↓25
    • MicrobiomeF. prausnitzii depleted
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Intermediate metabolizer
    Expected exposure
  • GLP1R rs6923761 A
    Altered receptor sensitivity
  • MTHFR C677T
    Reduced folate turnover
Microbiome
Shannon diversity 2.9 · butyrate capacity 54/100
  • Akkermansia muciniphilaNormal
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisHigh
  • Bifidobacterium longumLow
  • EnterobacteriaceaeHigh
Wearable, last 14 days
daily evolution fed into the runtime
HRV
42 ms
Sleep
7.4 h
Steps
9,268
Resting HR
70 bpm
Daily log: GI score 16, nutritional resilience 72, adherence 96.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the dose at the same time relative to your evening meal
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
PatientSimilarityBaselineInterventionOutcomeResponse today
P-0255550%S01AD-05no change79
P-0227745%S05AD-05improved92
P-0201346%S14BR-03no change94
P-0228246%S01BR-03no change88
P-0219340%S11CR-01improved87
P-0235431%S01CR-01improved78
P-0224941%S09DT-01improved100
P-0256539%S09DT-01no change79
P-0233735%S18DT-01no change100
P-0251830%S17DT-01improved68
P-0246229%S12DT-01improved65
P-0249128%S09DT-01no change65